PRATI, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 20.028
AS - Asia 10.753
EU - Europa 10.058
SA - Sud America 1.457
AF - Africa 182
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 12
Totale 42.513
Nazione #
US - Stati Uniti d'America 19.662
SG - Singapore 3.382
CN - Cina 3.050
IT - Italia 2.668
GB - Regno Unito 2.545
SE - Svezia 1.373
VN - Vietnam 1.287
HK - Hong Kong 1.158
BR - Brasile 1.100
DE - Germania 772
UA - Ucraina 519
RU - Federazione Russa 461
FR - Francia 435
FI - Finlandia 405
TR - Turchia 396
KR - Corea 355
IN - India 221
BD - Bangladesh 207
CA - Canada 183
BG - Bulgaria 179
NL - Olanda 159
MX - Messico 119
JP - Giappone 111
AR - Argentina 107
ID - Indonesia 102
IQ - Iraq 92
PL - Polonia 82
BE - Belgio 76
ES - Italia 76
IE - Irlanda 74
EC - Ecuador 61
CO - Colombia 54
ZA - Sudafrica 52
PK - Pakistan 49
LT - Lituania 45
RO - Romania 39
UZ - Uzbekistan 39
AE - Emirati Arabi Uniti 34
CL - Cile 33
CH - Svizzera 31
MA - Marocco 31
AT - Austria 30
PE - Perù 27
MY - Malesia 25
PH - Filippine 25
VE - Venezuela 25
JO - Giordania 23
SA - Arabia Saudita 21
AU - Australia 19
AZ - Azerbaigian 19
NP - Nepal 18
TH - Thailandia 18
TN - Tunisia 18
KZ - Kazakistan 17
KE - Kenya 16
PY - Paraguay 16
BO - Bolivia 15
IR - Iran 15
JM - Giamaica 15
EE - Estonia 14
TW - Taiwan 14
UY - Uruguay 14
EG - Egitto 13
ET - Etiopia 13
IL - Israele 12
DZ - Algeria 11
OM - Oman 10
MD - Moldavia 9
PT - Portogallo 9
CZ - Repubblica Ceca 8
HN - Honduras 8
LB - Libano 8
PA - Panama 8
AL - Albania 7
EU - Europa 7
QA - Qatar 7
BH - Bahrain 6
DO - Repubblica Dominicana 6
GR - Grecia 6
GT - Guatemala 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
SN - Senegal 6
CI - Costa d'Avorio 5
CR - Costa Rica 5
HU - Ungheria 5
NI - Nicaragua 5
RS - Serbia 5
DK - Danimarca 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
GY - Guiana 3
ML - Mali 3
NO - Norvegia 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
Totale 42.465
Città #
Singapore 2.091
Santa Clara 2.044
Ashburn 1.774
Southend 1.634
Chandler 1.384
Fairfield 1.360
Hefei 1.185
Woodbridge 1.164
Hong Kong 1.133
Jacksonville 956
Houston 851
Dearborn 737
San Jose 734
Nyköping 687
Ann Arbor 676
Beijing 527
Wilmington 521
Seattle 501
Cambridge 465
London 465
Council Bluffs 388
Ho Chi Minh City 384
Seoul 322
Los Angeles 317
Hanoi 310
Modena 267
The Dalles 261
Helsinki 237
Chicago 227
Des Moines 211
New York 209
Milan 193
Izmir 189
Princeton 188
Dallas 172
Sofia 172
Eugene 154
San Diego 153
Lauterbourg 143
Shanghai 134
Buffalo 113
São Paulo 113
Berlin 109
Redwood City 106
Moscow 94
Orem 91
Rome 75
Tokyo 73
Warsaw 70
Salt Lake City 69
Dublin 62
Fremont 62
Da Nang 61
Bologna 56
Munich 56
Brooklyn 54
Chennai 54
Denver 54
Reggio Emilia 53
Brussels 52
Jakarta 52
Frankfurt am Main 50
Phoenix 50
Atlanta 49
Boardman 46
Bremen 46
Haiphong 46
Montreal 46
Guangzhou 45
Amsterdam 43
Kunming 42
Mexico City 42
Yalova 41
Kent 40
Toronto 39
Elk Grove Village 38
Tampa 38
Columbus 35
Parma 35
Tashkent 35
Rio de Janeiro 33
Baghdad 32
Manchester 32
Florence 31
Falls Church 30
Miano 30
Johannesburg 29
Norwalk 27
Stockholm 27
San Francisco 26
Belo Horizonte 25
Austin 24
Boston 24
Nanjing 24
Hải Dương 23
Vancouver 23
Curitiba 22
Dhaka 22
Poplar 22
Quito 22
Totale 28.383
Nome #
Sintesi di alogenuri vinilici e gem-dialogenuri da aldeidi e chetoni 1.018
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase 822
A Mild Synthesis of Vinyl Halides and gem-Dihalides Using Triphenyl Phosphite–Halogen-based Reagents 434
Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors 394
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors 393
Sintesi di Nitrili da Ammidi: Degradazione di Von Braun in Condizioni Blande 389
Chemo-enzymatic synthesis of levodropropizine 386
Effetto del Bromuro di Allile e dell'Alcool Allilico nella Riduzione con Lievito di Composti Carbonilici alfa-Alogenati 384
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 382
Isolation, structure elucidation and total synthesis of a cytotoxic dienone from Echinacea pallida 373
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa 364
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design 356
A mild synthesis of nitriles by von Braun degradation of amides using triphenyl phosphite-halogen-based reagents 354
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols 345
(R)-(+) and (S)-(-) ethyl 4,4,4-trifluoro-3-hydroxy butanoate by enantioselective Baker's yeast reduction 342
An Easy Route to Enantiomerically Enriched 7- and 8-Hydroxy-stearic Acids by Olefin-Metathesis-Based Approach 334
Ligand-Induced Proton Transfer and Low-Barrier Hydrogen Bond Revealed by X-ray Crystallography 333
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii 332
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 328
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes 324
A novel approach to a precursor of the carbapenem antibiotic PS-5 via aziridine stereospecific carbonylation 321
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 321
Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) 316
A very mild access to 3,4-dihydroisoquinolines using triphenyl phosphite-bromine-mediated Bischler-Napieralski-type cyclization 314
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases 312
Enzymatic Resolution of Chiral N-Alkyloxaziridine-3,3-dicarboxylic Esters 308
Chimica Organica 307
Alkene Metathesis in Organic Synthesis 306
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors 306
Enantioselective total synthesis of (-)-microcarpalide 304
Sintesi Stereoselettiva di Acidi Boronici Inibitori di beta-Lattamasi 304
'Ligand-free-like' CuCl-catalyzed atom transfer radical cyclization of N-substituted N-allyl polychloroamides to γ-lactams. 302
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 301
Candida Cylindracea Lipase Catalysed Hydrolysis of Methyl Aziridine 2-Carboxylates and 2,3-Dicarboxylates. 300
Optimizing Cell Permeation of an Antibiotic Resistance Inhibitor for Improved Efficacy 294
The triphenyl phosphite-chlorine reagent in the synthesis of pyrroles from N-allylamides 293
Synthesis, characterization and metal coordination of a potential β-lactamase inhibitor: 5-Methyl-2-phenoxymethyl-3-H-imidazole-4-carboxylic acid (PIMA) 292
A mild synthesis of nitriles by TPPX2-promoted dehydration of primary amides 291
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method 290
Biotransformations of Fluorinated Sulphenyl and Sulphonyl Compounds 289
Partecipazione a Spin Off 289
Catalisi Enzimatica nella Sintesi di Prodotti Fluorurati Chirali 288
One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted1,5-Electrocyclization of Azavinyl Azomethine Ylides 287
Paternó-Büchi reaction versus hydrogen abstraction in the photochemical reactivity of alkenyl boronates with benzophenone 286
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 284
Enzymatic Resolution of Aziridine-Carboxylates 277
Applications of the (PhO)(3)PCl2 reagent: A new protocol for mild cleavage of sulfinamides and sulfonamides 277
Electron and electrospray ionization mass spectrometry in the characterization of some 1-allyl-3-phenylaziridines 276
alpha- and beta-Aminoacids from Optically-Active Aziridine-2-Carboxylates 276
Derivatives of Optically Active 1-Chloro-2,2-bismethoxycarbonylaziridine: Absolute Configuration and X-Ray Molecular Structure of (-)-(E)-1-Chloro-2- methoxycarbonyl- 2-methylcarbamoylaziridine. 276
Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria 275
Total synthesis of )-microcarpalide, a novel microfilament disrupting metabolite 274
Nanomolar inhibitors of AmpC beta-lactamase 273
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli 272
Chiroptical Properties of (S)-(-) Methyl Glycolate-d1 269
Biotrasformazioni di Composti Fluorurati 269
Total synthesis of a dienynone from Echinacea pallida 268
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii 268
Enantioselective Synthesis of (S)-(Ð)-5,5,5-Trifluoro-4-Hydroxy-2-Pentanone by Baker's Yeast Reduction. 267
A Chemoenzymatic Approach to beta-Lactams from Hydroxymethyl Aziridines 264
Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections 263
Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder 262
Synthesis of N-bridgehead fused bicyclic beta-lactams through organometal-mediated transformations of 1,2-dialkenylaziridines 261
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase 258
Lipase-Catalyzed Resolution and Desymmetrization of 2-Hydroxymethylaziridines 256
Isolation, structure elucidation, synthesis and cytotoxic activity of polyacetylenes and polyenes from Echinacea pallida 256
α-Aminoester-Derived Imidazoles by 1,5-Electrocyclization of Azavinyl Azomethine Ylides 256
Low-temperature deacylation of N-monosubstituted amides 254
Sintesi Stereospecifiche di beta-Lattami da Aziridine 253
Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin binding protein 252
Highly enantioselective reduction of ethyl 4-chloro-3-oxobutanoate to L-and D-3-hydroxyesters with baker`s yeast 251
Novel Insights into the mode of inhibition of class A SHV-1 β-lactamase revealed by boronic acid transition state inhibitors 251
Inhibition of Acinetobacter -Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors 247
Chiroptical Properties of (S)-(-) Methyl Glycolate 246
alpha- and beta-Aminoacids from Optically-Active Aziridine-2-Carboxylates 246
Chimica Organica 245
Optically Active cis- and trans-1-Chloro-2-methoxycarbonyl-2-methylcarbamoyl-aziridines. Stereochemical Properties 245
Optically Active α-Phenylethylamine as Efficient Organocatalyst in the Solvent-free Reactions Between 2,3-Butanedione and Conjugated Nitroolefins 242
Sintesi Asimmetrica Biocatalitica di (S)-(–)-Timolo 241
Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase 241
Isolation, structure elucidation, synthesis and cytotoxic activity of polyacetylenes and polyenes from Echinacea pallida 241
Straightforward synthesis of chiral non-racemic α-boryl isocyanides 241
Fragment-guided Design of Subnanomolar β-Lactamase Inhibitors Active in vivo 238
An efficient and versatile synthesis of new Trojan-horse cephalosporins 237
Approcci sintetici alla 6-epi-decarestrictina C1 237
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses 236
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 236
High adaptability of the omega loop underlies the substrate-spectrum-extension evolution of a class A β-lactamase, PenL 235
Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors 234
Enzymatic Resolution of Aziridine- and Oxaziridine-Carboxylates 233
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. 233
Absolute Configuration of 1-Chloro-2,2-bismethoxycarbonylaziridine and Derivatives 233
Aziridine Bicicliche con Azoto a Testa di Ponte: Sintesi, Espansione Carbonilativa a beta- Lattami Biciclici 232
Structural Studies of N-Chloroaziridinecarboxylates by Multinuclear NMR Spectroscopy 229
Enantioselective Lipase-Catalyzed Acetylation of beta-Lactams Precursors of Carbapenem Antibiotics 229
Characterization of 2-Phenylaziridine Derivatives: Tandem MS and MSn Experiments Under Electron Ionization and ESI Conditions 228
The structures of Ceftazidime and Its Transition State Analog in Complex with AmpC-beta-lactamase: Implication for Resistance Mutation and Inhibitor Design 226
Synthesis of [(1,2,3-Triazol-1-yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors 226
Stereochemistry of Nucleophilic Ring-Opening Reactions of Optically Active N-Acetyl-2-Methoxycarbonylaziridine 224
Structure-based optimization of cephalotin analogue boronic acids as beta-lactamase inhibitors 224
Totale 29.651
Categoria #
all - tutte 148.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 0 0 179
2021/20223.027 150 351 246 263 135 190 131 156 316 207 524 358
2022/20233.816 475 427 263 405 400 659 99 324 459 35 126 144
2023/20242.347 96 150 106 247 391 258 406 237 74 84 80 218
2024/20257.704 355 115 187 475 1.424 1.178 469 539 733 238 758 1.233
2025/202613.715 918 741 1.299 1.702 1.968 1.240 1.594 641 1.294 1.311 813 194
Totale 42.687